Estrada–Reyes, Rosa et al. Comparative chemical composition of Agastache mexicana subsp. mexicana and A. mexicana subsp. xolocotziana. Biochemical Systematics and Ecology 32 (2004) 685–694.
Hernandez–Abreu, Oswaldo et al. Antihypertensive and vasorelaxant effects of tilianin isolated from Agastache mexicana are mediated by NO/cGMP pathway and potassium channel opening. Biochemical Pharmacology 78 (2009) 54–61.
Hong, Jung–Joo et al. Inhibition of cytokine–induced vascular cell adhesion molecule–1 expression; possible mechanism for anti–atherogenic effect of Agastache rugosa. FEBS Letters 495 (2001) 142–147.
Lawrence, B.M. et al. Gill. Terpenoid composition of some Canadian Labiatae. Phytochemistry 11 (1972) 2638–2639.
Vogelmann, James E. Flavonoids of Agastache section Agastache. Biochemical Systematics and Ecology 12, 4 (1984) 363–366.
Copland, A., L. Nahar, C.T.M. Tomlinson, V. Hamilton, M.Middleton, Y.Kumarasamy, and S.D. Sarker. “Antibacterial and Free Radical Scavenging Activity of the Seeds of Agrimonia Eupatoria.” Fitoterapia 74 (2003): 133–135.
Venskutonis, P.R., M. Škėmaitė, and B. Sivik. “Assessment of Radical Scavenging Capacity of Agrimonia Extracts Isolated by Supercritical Carbon Dioxide.” J. of Supercritical Fluids 45 (2008): 231–237.
Chithra, P., G.B. Sajithlal, and Gowri Chandrakasan. “Influence of Aloe Vera on the Glycosaminoglycans in the Matrix of Healing Dermal Wounds in Rats.” Journal of Ethnopharmacology 59 (1998): 179–186.
D.N. Herndon and J.P. Heggers. “Retardation of Wound Healing by Silver Sulfadiazine is Reversed by Aloe Vera and Nystatin.” Burns 29 (2003): 834–836.
Seyger, M.M.B., P.C.M. van de Kerkhof, I.M.J.J. van Vlijmen–Willems, E.S.M. de Bakker, F. Zwiers, and E.M.G.J. de Jong. “The Efficacy of a New Topical Treatment for Psoriasis: Mirak.” Journal of the European Academy of Dermatology and Venereology 11 (1998): 13–18.